934715-41-0

Basic information

• Product Name: 2-(2-{2-[2-(2-tert-butoxycarbonylamino-4-methyl-pentanoylamino)-4-methyl-pentanoylamino]-butyrylamino}-4-methyl-pentanoylamino)-3-phenyl-propionic acid methyl ester
• Synonyms: 2-(2-{2-[2-(2-tert-butoxycarbonylamino-4-methyl-pentanoylamino)-4-methyl-pentanoylamino]-butyrylamino}-4-methyl-pentanoylamino)-3-phenyl-propionic acid methyl ester
• CAS NO: 934715-41-0
• Molecular Weight: 703.92
• Mol File: 934715-41-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(2-{2-[2-(2-tert-butoxycarbonylamino-4-methyl-pentanoylamino)-4-methyl-pentanoylamino]-butyrylamino}-4-methyl-pentanoylamino)-3-phenyl-propionic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-{2-[2-(2-tert-butoxycarbonylamino-4-methyl-pentanoylamino)-4-methyl-pentanoylamino]-butyrylamino}-4-methyl-pentanoylamino)-3-phenyl-propionic acid methyl ester(934715-41-0)
• EPA Substance Registry System: 2-(2-{2-[2-(2-tert-butoxycarbonylamino-4-methyl-pentanoylamino)-4-methyl-pentanoylamino]-butyrylamino}-4-methyl-pentanoylamino)-3-phenyl-propionic acid methyl ester(934715-41-0)

Safety Data

• Hazardous Substances Data: 934715-41-0(Hazardous Substances Data)

Upstream product

• 87976-66-7 Boc-D-Leu-Phe-OMe 
• 63792-75-6 D-Leu-Phe-OMe 
• 15136-13-7 N-tert-butoxycarbonyl-L-leucyl-L-leucine methyl ester 
• 16937-99-8 N-Boc-D-Leu 
• 2577-90-4 methyl (2S)-2-amino-3-phenylpropanoate 
• 2666-93-5 (S)-Leu-OMe 
• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 
• 934715-39-6 2-[2-(2-tert-butoxycarbonylamino-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester 
• 934715-40-9 2-[2-(2-amino-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid methyl ester 
• 73401-65-7 (S)-2-((S)-2-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-4-methyl-pentanoic acid 

Downstream Products

• 934715-78-3 2-(2-{2-[2-(2-amino-4-methyl-pentanoylamino)-4-methyl-pentanoylamino]-butyrylamino}-4-methyl-pentanoylamino)-3-phenyl-propionic acid 

Relevant articles and documents

Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines

We report an extensive structure-activity relationship (SAR) of 62 compounds active against two drug-resistant colon cancer cell lines. Our comprehensive evaluation of two generations of compounds utilizes SAR, NMR, and molecular modeling to evaluate the